BCAL Diagnostics Limited · ASX:BDX

Jayne Shaw bought 67,685 BCAL Diagnostics Limited shares (Appendix 3Y, ASX)

Traded Nov 17, 2026 · Filed Nov 18, 2026

On Nov 17, 2026, Jayne Shaw (Director) bought 67,685 BCAL Diagnostics Limited shares at AUD 0.06 for AUD 4,036. Filed Nov 18, 2026 (Appendix 3Y, ASX).

Bought
67,685 shares
Price
AUD 0.06
Value
AUD 4,036
Role
Director

The filing in full

Appendix 3Y

*Rule 3.19A.2*

Change of Director’s Interest Notice

*Information or documents not available now must be given to ASX as soon as available. Information and
documents given to ASX become ASX’s property and may be made public.*

Introduced 30/9/2001.

Name of entityBCAL DIAGNOSTICS LIMITED
ABN51 142 051 223

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the
director for the purposes of section 205G of the Corporations Act.

Name of DirectorJayne Shaw
Date of last notice11 November 2026

Part 1 - Change of director’s relevant interests in securities

*In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust*

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be
disclosed in this part.

Direct or indirect interestDirect & Indirect
Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest.Entities controlled by the Director
Date of change17 November 2026
No. of securities held prior to changeNabelle Pty Ltd 22,986,662 ordinary shares Nabelle Pty Ltd 1,742,025 ordinary shares Nabelle Pty Ltd 6,394,796 ordinary shares OPSC Pty Ltd 2,651,779 ordinary shares Jayne Shaw Ordinary shares 2,022,638 Jayne Shaw 2,000,000 options exercise price $0.25 expiry date 8 October 2027.
ClassOrdinary shares
Number acquired67,685

---

Number disposedNil
Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation$4,036
No. of securities held after changeNabelle Pty Ltd 22,986,662 ordinary shares Nabelle Pty Ltd 1,742,025 ordinary shares Nabelle Pty Ltd 6,462,481 ordinary shares OPSC Pty Ltd 2,651,779 ordinary shares Jayne Shaw Ordinary shares 2,022,638 Jayne Shaw 2,000,000 options exercise price $0.25 expiry date 8 October 2027.
Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-backOn Market Purchase

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be
disclosed in this part.
Detail of contract N/A

Detail of contractN/ANature of interestName of registered holder (if issued securities)Date of changeNo. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changedInterest acquiredInterest disposedValue/Consideration Note: If consideration is non-cash, provide details and an estimated valuationInterest after changePart 3 – +Closed periodWere the interests in the securities or contracts detailed above traded during a +closed period where prior written clearance was required?NoIf so, was prior written clearance provided to allow the trade to proceed during this period?N/AIf prior written clearance was provided, on what date was this provided?N/A

  • See chapter 19 for defined terms.
DateSecurityTransactionSharesPriceHolding afterOwnership
Nov 17, 2026Ordinary sharesBuy67,685AUD 0.06

Source

Download PDF · View original at ASX

Related